Alexander Lonshteyn

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Chemotherapy Induced

Clinical Practice

Sickle Cell Disease

Health Insurance

Top Venues

Current medical research and opinion

Expert review of hematology

Moscow State Automobile and Road Technical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Moscow State Automobile and Road Technical University Sep 01 1981 - Jun 22 1986

Russia

PHD :: Economics

Publications

Nirmish Shah, Thokozeni Lipato, Ofelia Alvarez, Thomas Delea, Alexander Lonshteyn, Derek Weycker, Andy Nguyen, Anne Beaubrun, Irene Agodoa
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis. Expert review of hematology 15 (2) (2022)
Derek Weycker, Mark E Bensink, Alexander Lonshteyn, Robin Doroff, David Chandler
Use of colony-stimulating factor primary prophylaxis and incidence of febrile neutropenia from 2010 to 2016: a longitudinal assessment. Current medical research and opinion 35 (6) (2019)
Derek Weycker, Ahuva Hanau, Alexander Lonshteyn, Charles Bowers, Tamer Garawin, Mark E Bensink, David Chandler
Risk of chemotherapy-induced febrile neutropenia with early discontinuation of pegfilgrastim prophylaxis: a retrospective evaluation using Medicare claims. Current medical research and opinion 35 (4) (2018)
Derek Weycker, Ahuva Hanau, Alexander Lonshteyn, Charles Bowers, Mark E Bensink, Tamer Garawin, David Chandler
Risk of chemotherapy-induced febrile neutropenia with same-day versus next-day pegfilgrastim prophylaxis among patients aged ≥65 years: a retrospective evaluation using Medicare claims. Current medical research and opinion 34 (9) (2018)